Search
for
Sort by
Research 151–180 of 502
- Cutaneous manifestations of systemic infection in children
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- The North American Menopause Society Recommendations for Clinical Care of Midlife Women
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- Wound Healing and the Use of Medicinal Plants
- Cutaneous manifestations of systemic lupus erythematosus
- Primary cicatricial alopecia
- Ritlecitinib: First Approval
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Graft-versus-host disease
- ACNE
- Adverse Reactions to Oral Retinoids An Update
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Emerging treatments in alopecia
- Skin disease in pregnancy
- Contemporary medical therapy for polycystic ovary syndrome
- Chemotherapy of psoriasis and other skin disorders with oral retinoids
- Bariatric Surgery and Its Effects on the Skin and Skin Diseases
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- Trichoscopic signs in systemic lupus erythematosus: a comparative study with 109 patients and 305 healthy controls
- Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data
- Skin manifestations among<i>GATA2</i>-deficient patients
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Guidelines for the Use of Acitretin in Psoriasis
- Interventions for morphea